Indian manufacturer meeting: Regulator sets tough tone, declines 'friend' request
This article was originally published in Scrip
Executive Summary
If the annual meeting of the Indian Drug Manufacturers' Association (IDMA) is anything to go by, then the drug regulatory regime in the country appears set for a significant makeover.